Mild hantaviral disease caused by sin nombre virus in a four–year–old child

Lori R. Armstrong, Ralph T. Bryan, John Sarisky, Ali S Khan, Thomas Rowe, Thomas Rowe, Paul J. Ettestad, James E. Cheek, C. J. Peters, Pierre Rollin, M. L. Martin, Thomas G. Ksiazek

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Fully intermittent short course chemotherapy regimens have been used successfully in adults but not in children. We report the results on 76 children with tuberculosis, excluding central nervous system tuberculosis and primary pulmonary complex. Isoniazid, rifampin and pyrazinamide were used for treatment. They were randomly allocated to Regimen A (52 doses) and Regimen B (94 doses). Overall efficacy of both schedules was >95% in 27 children with lymphatic, 43 with pulmonary and 6 with disseminated tuberculosis. Compliance in 10 children after 2 to 4 months of therapy was poor because rapid improvement was mistaken by parents for cure. Two children died, probably of underlying lung disease. Follow-up for up to 2 years did not reveal any case of relapse or recurrence of the disease. Therapy for 6 months involving administration of only 52 or 94 doses of drugs was found to be economical, effective and safe for treating children with tuberculosis.

Original languageEnglish (US)
Pages (from-to)1108-1110
Number of pages3
JournalPediatric Infectious Disease Journal
Volume14
Issue number12
StatePublished - Jan 1 1995

Fingerprint

Sin Nombre virus
Tuberculosis
Central Nervous System Tuberculosis
Pyrazinamide
Recurrence
Lung
Isoniazid
Rifampin
Lung Diseases
Compliance
Appointments and Schedules
Therapeutics
Parents
Drug Therapy

Keywords

  • Hantavirus infection
  • Hantavirus pulmonary syndrome
  • Sin nombre virus

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Armstrong, L. R., Bryan, R. T., Sarisky, J., Khan, A. S., Rowe, T., Rowe, T., ... Ksiazek, T. G. (1995). Mild hantaviral disease caused by sin nombre virus in a four–year–old child. Pediatric Infectious Disease Journal, 14(12), 1108-1110.

Mild hantaviral disease caused by sin nombre virus in a four–year–old child. / Armstrong, Lori R.; Bryan, Ralph T.; Sarisky, John; Khan, Ali S; Rowe, Thomas; Rowe, Thomas; Ettestad, Paul J.; Cheek, James E.; Peters, C. J.; Rollin, Pierre; Martin, M. L.; Ksiazek, Thomas G.

In: Pediatric Infectious Disease Journal, Vol. 14, No. 12, 01.01.1995, p. 1108-1110.

Research output: Contribution to journalArticle

Armstrong, LR, Bryan, RT, Sarisky, J, Khan, AS, Rowe, T, Rowe, T, Ettestad, PJ, Cheek, JE, Peters, CJ, Rollin, P, Martin, ML & Ksiazek, TG 1995, 'Mild hantaviral disease caused by sin nombre virus in a four–year–old child', Pediatric Infectious Disease Journal, vol. 14, no. 12, pp. 1108-1110.
Armstrong LR, Bryan RT, Sarisky J, Khan AS, Rowe T, Rowe T et al. Mild hantaviral disease caused by sin nombre virus in a four–year–old child. Pediatric Infectious Disease Journal. 1995 Jan 1;14(12):1108-1110.
Armstrong, Lori R. ; Bryan, Ralph T. ; Sarisky, John ; Khan, Ali S ; Rowe, Thomas ; Rowe, Thomas ; Ettestad, Paul J. ; Cheek, James E. ; Peters, C. J. ; Rollin, Pierre ; Martin, M. L. ; Ksiazek, Thomas G. / Mild hantaviral disease caused by sin nombre virus in a four–year–old child. In: Pediatric Infectious Disease Journal. 1995 ; Vol. 14, No. 12. pp. 1108-1110.
@article{8f857c19abf24922be006b8c62f74edc,
title = "Mild hantaviral disease caused by sin nombre virus in a four–year–old child",
abstract = "Fully intermittent short course chemotherapy regimens have been used successfully in adults but not in children. We report the results on 76 children with tuberculosis, excluding central nervous system tuberculosis and primary pulmonary complex. Isoniazid, rifampin and pyrazinamide were used for treatment. They were randomly allocated to Regimen A (52 doses) and Regimen B (94 doses). Overall efficacy of both schedules was >95{\%} in 27 children with lymphatic, 43 with pulmonary and 6 with disseminated tuberculosis. Compliance in 10 children after 2 to 4 months of therapy was poor because rapid improvement was mistaken by parents for cure. Two children died, probably of underlying lung disease. Follow-up for up to 2 years did not reveal any case of relapse or recurrence of the disease. Therapy for 6 months involving administration of only 52 or 94 doses of drugs was found to be economical, effective and safe for treating children with tuberculosis.",
keywords = "Hantavirus infection, Hantavirus pulmonary syndrome, Sin nombre virus",
author = "Armstrong, {Lori R.} and Bryan, {Ralph T.} and John Sarisky and Khan, {Ali S} and Thomas Rowe and Thomas Rowe and Ettestad, {Paul J.} and Cheek, {James E.} and Peters, {C. J.} and Pierre Rollin and Martin, {M. L.} and Ksiazek, {Thomas G.}",
year = "1995",
month = "1",
day = "1",
language = "English (US)",
volume = "14",
pages = "1108--1110",
journal = "Pediatric Infectious Disease Journal",
issn = "0891-3668",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Mild hantaviral disease caused by sin nombre virus in a four–year–old child

AU - Armstrong, Lori R.

AU - Bryan, Ralph T.

AU - Sarisky, John

AU - Khan, Ali S

AU - Rowe, Thomas

AU - Rowe, Thomas

AU - Ettestad, Paul J.

AU - Cheek, James E.

AU - Peters, C. J.

AU - Rollin, Pierre

AU - Martin, M. L.

AU - Ksiazek, Thomas G.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Fully intermittent short course chemotherapy regimens have been used successfully in adults but not in children. We report the results on 76 children with tuberculosis, excluding central nervous system tuberculosis and primary pulmonary complex. Isoniazid, rifampin and pyrazinamide were used for treatment. They were randomly allocated to Regimen A (52 doses) and Regimen B (94 doses). Overall efficacy of both schedules was >95% in 27 children with lymphatic, 43 with pulmonary and 6 with disseminated tuberculosis. Compliance in 10 children after 2 to 4 months of therapy was poor because rapid improvement was mistaken by parents for cure. Two children died, probably of underlying lung disease. Follow-up for up to 2 years did not reveal any case of relapse or recurrence of the disease. Therapy for 6 months involving administration of only 52 or 94 doses of drugs was found to be economical, effective and safe for treating children with tuberculosis.

AB - Fully intermittent short course chemotherapy regimens have been used successfully in adults but not in children. We report the results on 76 children with tuberculosis, excluding central nervous system tuberculosis and primary pulmonary complex. Isoniazid, rifampin and pyrazinamide were used for treatment. They were randomly allocated to Regimen A (52 doses) and Regimen B (94 doses). Overall efficacy of both schedules was >95% in 27 children with lymphatic, 43 with pulmonary and 6 with disseminated tuberculosis. Compliance in 10 children after 2 to 4 months of therapy was poor because rapid improvement was mistaken by parents for cure. Two children died, probably of underlying lung disease. Follow-up for up to 2 years did not reveal any case of relapse or recurrence of the disease. Therapy for 6 months involving administration of only 52 or 94 doses of drugs was found to be economical, effective and safe for treating children with tuberculosis.

KW - Hantavirus infection

KW - Hantavirus pulmonary syndrome

KW - Sin nombre virus

UR - http://www.scopus.com/inward/record.url?scp=0029589694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029589694&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 1108

EP - 1110

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

SN - 0891-3668

IS - 12

ER -